Oh damn, this will be the coming Wed, in 3 more sleeps.
Merck is talking to Australia directly with licensing/partnering activities. Tell me there is nothing to do with eftilagimod.
And look at the reply in below, directly from their licensing team from the oncology branch.
Media, page-711
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.8¢ |
Change
-0.013(2.98%) |
Mkt cap ! $594.7M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 42.5¢ | 40.5¢ | $554.7K | 1.342M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 198679 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 217923 | 21 |
View Market Depth
| Last trade - 13.20pm 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
40.5¢ |
Change
-0.013 ( 3.91 %) |
||||
| Open | High | Low | Volume | ||
| 41.5¢ | 42.5¢ | 40.5¢ | 359383 | ||
| Last updated 13.26pm 18/06/2024 ? | |||||
| IMM (ASX) Chart |